Terns Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Terns Pharmaceuticals Inc cash flow-to-debt ratio. Terns Pharmaceuticals Inc (TERN) has a Cash Flow-to-Debt Ratio of -1.12x as of September 2025, meaning its operating cash flow of $-19.77 Million could theoretically repay -1% of its total liabilities ($17.59 Million) in one year. See TERN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Terns Pharmaceuticals Inc (2018–2024)
Cash flow-to-debt ratio of Terns Pharmaceuticals Inc from 2018 to 2024. Historical debt coverage capacity for Terns Pharmaceuticals Inc across 7 annual periods. Also explore Terns Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Terns Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
Terns Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Terns Pharmaceuticals Inc. For the full cash flow conversion analysis, see TERN operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.88x | $-70.02 Million | $18.06 Million | ▲ +24.3% |
| 2023 | -5.12x | $-67.39 Million | $13.15 Million | ▼ -5.2% |
| 2022 | -4.87x | $-49.11 Million | $10.08 Million | ▲ +9.6% |
| 2021 | -5.39x | $-41.83 Million | $7.77 Million | ▼ -328.1% |
| 2020 | -1.26x | $-29.81 Million | $23.70 Million | ▲ +89.4% |
| 2019 | -11.87x | $-66.22 Million | $5.58 Million | ▼ -1006.1% |
| 2018 | -1.07x | $-18.07 Million | $16.84 Million | — |